People: Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

8:59pm IST
Change (% chg)

€0.01 (+1.33%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bordignon, Claudio 

Prof. Claudio Bordignon serves as Chairman of the Board of Molecular Medicine S.p.A. since November 6, 2007. He was also Chief Executive Officer at the firm from November 6, 2007 to December 11, 2015. He also acts as the Chairman of the Scientific Advisory Board of the Company. He is Founder of the Company and Pioneer in genetic and molecular therapy. He has produced publications and holds several patents in this field, which constitute one of the parts of the intellectual property of Molecular Medicine SpA. He headed the genetic therapy program and the bone marrow transplant unit of Istituto Scientifico San Raffaele, where he previously served as Scientific Director. In July 2005, he was Founding Member of the Scientific Board of the European Research Council. He is Professor of Hematology at the Medicine Faculty of Universita Vita-Salute San Raffaele di Milano. He gained a Doctorate of Medicine in Medicine from the Universita degli Studi di Milano and conducted studies and research in various institutions in the United Sates.

Basic Compensation

Total Annual Compensation, EUR 590,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 84,000
Fiscal Year Total, EUR 674,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --